论文部分内容阅读
目的:探讨酮替芬治疗哮喘的临床效果。方法:选取我院2014年4月-2016年6月期间收治的114例哮喘患者作为研究对象,将其随机分为观察组(酮替芬+常规药物治疗)和对照组(常规药物治疗)各57例,比较两组患者临床症状的控制效果将其恢复情况。结果:与对照组相比,观察组患者的PEF、FEV1、FEV1%等各项指标明显更优,其治疗有效率相对更高,而不良反应发生率更低,对比差异具有统计学意义(P<0.05)。结论:在常规药物治疗哮喘的基础上,联合应用酮替芬,能够进一步提升哮喘症状的控制效果,提高治疗的有效性和安全性,其具有很高的临床应用价值。
Objective: To investigate the clinical efficacy of ketotifen in the treatment of asthma. Methods: A total of 114 patients with asthma who were treated in our hospital from April 2014 to June 2016 were selected as study subjects and randomly divided into observation group (ketotifen + conventional drug treatment) and control group (conventional drug treatment) 57 cases, comparing the clinical efficacy of the two groups of patients to control the recovery. Results: Compared with the control group, the indexes of PEF, FEV1, FEV1% in the observation group were significantly better, the treatment efficiency was higher and the incidence of adverse reactions was lower, the difference was statistically significant (P <0.05). CONCLUSION: Combined use of ketotifen can further improve the control effect of asthma symptoms and improve the effectiveness and safety of treatment based on the conventional treatment of asthma, which has high clinical value.